Stocks
Funds
Screener
Sectors
Watchlists

Latest Artal Group S.A. Stock Portfolio

About Artal Group S.A. and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Artal Group S.A. reported an equity portfolio of $2.4 Billions as of 30 Sep, 2024.

The top stock holdings of Artal Group S.A. are , LXRX, . The fund has invested 91% of it's portfolio in CAVA GROUP INC and 9% of portfolio in LEXICON PHARMACEUTICALS INC.

The fund managers got completely rid off SCHOLAR ROCK HOLDING CORP (SRRK), KYMERA THERAPEUTICS INC (KYMR) and MORPHIC HOLDING INC (MORF) stocks. They significantly reduced their stock positions in CAVA GROUP INC and LEXICON PHARMACEUTICALS INC (LXRX).

Artal Group S.A. Annual Return Estimates Vs S&P 500

New Buys

No new stocks were added by Artal Group S.A.

Additions

No additions were made to existing positions by Artal Group S.A.

Reductions

Ticker% Reduced
cava group inc-25.52
lexicon pharmaceuticals inc-22.23

Artal Group S.A. reduced stake in above stock

Sold off

Ticker$ Sold
gossamer bio inc-11,990,000
scholar rock holding corp-93,791,100
erasca inc-22,728,700
glycomimetics inc-2,418,680
allovir inc-4,771,730
seer inc-7,980,000
wave life sciences ltd-22,785,600
taysha gene therapies inc-9,753,440

Artal Group S.A. got rid off the above stocks

Sector Distribution

Sector%
Others91
Healthcare9

Market Cap. Distribution

Category%
UNALLOCATED91
SMALL-CAP9

Stocks belong to which Index?

Index%
Others91
RUSSELL 20009
Top 5 Winners (%)%
Top 5 Winners ($)$
Top 5 Losers (%)%
LXRX
lexicon pharmaceuticals inc
-4.8 %
Top 5 Losers ($)$
LXRX
lexicon pharmaceuticals inc
-14.2 M

Artal Group S.A. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Artal Group S.A.

Last Reported on: 13 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions